A Phase 3, Double-Blind, Multi-Center, Non-Inferiority, Randomized Study To Examine the Efficacy and Safety of LCP-Tacro™ Tablets, Once Daily, Compared to Prograf® Capsules, Twice Daily, in Combination with Mycophenolate Mofetil in De Novo Adult Kidney Transplantation: Baseline Characteristics.

被引:0
|
作者
Rostaing, L. [1 ]
Budde, K. [2 ]
Bunnapradist, S. [3 ]
机构
[1] Univ Hosp Toulouse Rangueil, Toulouse, France
[2] Charite, Dept Nephrol, D-13353 Berlin, Georgia, Germany
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:339 / 339
页数:1
相关论文
共 21 条
  • [1] ONCE-DAILY LCP-TACRO DEMONSTRATES COMPARABLE EFFICACY AND SAFETY TO TWICE-DAILY PROGRAF: A PHASE 3 STUDY FOR PREVENTION OF ACUTE ALLOGRAFT REJECTION IN DE NOVO ADULT KIDNEY TRANSPLANT RECIPIENTS
    Rostaing, Lionel
    Budde, Klemens
    Ciechanowski, Kazimierz
    Bunnapradist, Suphamai
    Silva, Helio
    Grinyo, Josep Maria
    TRANSPLANT INTERNATIONAL, 2013, 26 : 171 - 171
  • [2] A Phase 2 Randomized Study of the Pharmacokinetics, Safety and Efficacy of LCP-Tacro Tablets Once-a-Day vs Prograf Capsules Twice-a-Day in De Novo Kidney Transplants
    Alloway, R.
    Mulgaonkar, S.
    Ueda, K.
    Cohen, D.
    Kaplan, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 355 - 355
  • [3] A Phase 2 Randomized Study of the Pharmacokinetics, Safety and Efficacy of LCP-Tacro™ Tablets Once-a-Day vs. Prograf® Capsules Twice-a-Day in De Novo Liver Transplants
    Feng, S.
    Chapman, W. C.
    DuBay, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 239 - 239
  • [4] A Phase 2b, Open-Label, Multi-Center, Prospective, Randomized Study To Compare the Pharmacokinetics and Safety of LCP-Tacro™ Tablets Once-a-Day to Prograf® Capsules Twice-a-Day in De Novo Kidney Transplant Patients.
    Alloway, Rita R.
    Mulgaonkar, Shamkant
    Bowers, Victor D.
    Stevenson, Kimi R. Ueda
    Cohen, David J.
    Katz, Eliezer
    Kosar, Hana
    Gordon, Robert D.
    Hamberg, Karin J.
    Chodoff, Lawrence
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 414 - 414
  • [5] Tacrolimus Once-Daily (Advagrat) Versus Twice-Daily (Prograf) in De Novo Liver Transplantation; a Multi-Center Randomized Phase III Study Comparing Safety and Efficacy
    Tan, T'zu-Jen
    Chen, Chao-Long
    Lee, Wei-Chen
    Loong, Che-Chuan
    Lee, Po-Huang
    Yong, Chee-Chien
    Chou, Hong-Shiue
    Hsia, Cheng-Yuan
    Liu, Chin-Su
    Hu, Rey-Heng
    LIVER TRANSPLANTATION, 2011, 17 (06) : S263 - S263
  • [6] A PHASE 2b, OPEN-LABEL, MULTI-CENTER, PROSPECTIVE, RANDOMIZED STUDY TO COMPARE THE PHARMACOKINETICS AND SAFETY OF LCP-TACRO™ TABLETS ONCE-A-DAY TO PROGRAF® CAPSULES TWICE-A-DAY IN DE NOVO LIVER TRANSPLANT PATIENTS
    DuBay, DerekA.
    Alloway, Rita R.
    Alsina, Angel E.
    Chapman, William C.
    Katz, Eliezer
    Griffin, H. Eugene
    Gordon, Robert D.
    Hamberg, Karin J.
    Chodoff, Lawrence
    LIVER TRANSPLANTATION, 2009, 15 (07) : S134 - S135
  • [7] A PHASE 2b, OPEN-LABEL, MULTI-CENTER, PROSPECTIVE, RANDOMIZED STUDY TO COMPARE THE PHARMACOKINETICS AND SAFETY OF LCP-Tacro™ TABLETS ONCE-A-DAY TO PROGRAF® CAPSULES TWICE-A-DAY IN DE NOVO LIVER TRANSPLANT PATIENTS
    DuBay, Derek A.
    Alloway, Rita R.
    Alsina, Angel E.
    Chapman, William C.
    Feng, Sandy
    Tzakis, Andreas G.
    Teperman, Lewis W.
    Katz, Eliezer
    Griffin, H. Eugene
    Gordon, Robert D.
    Hamberg, Karin J.
    Chodoff, Lawrence
    TRANSPLANT INTERNATIONAL, 2009, 22 : 116 - 116
  • [8] Two-Year Results of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) vs Prograf (Twice-Daily Tacrolimus Capsules): A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study
    Rostaing, L.
    Ciechanowski, K.
    Bunnapradist, S.
    Silva, H., Jr.
    Grinyo, J.
    Budde, K.
    TRANSPLANTATION, 2014, 98 : 661 - 662
  • [9] Two-Year Results of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) vs Prograf (Twice-Daily Tacrolimus Capsules): A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study.
    Rostaing, L.
    Ciechanowski, K.
    Bunnapradist, S.
    Silva, H., Jr.
    Grinyo, J.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 661 - 662
  • [10] Improved Bioavailability and Reduced Dose Requirements of Novel, Once-Daily, MeltDose® Tacrolimus Formulation Tablets (Envarsus® XR) Compared to Twice-Daily Tacrolimus Capsules (Prograf®) in De Novo Kidney Transplantation: Results of a Phase 3 Double-Dummy, Randomized Trial
    Grinyo, J.
    Bunnapradist, S.
    Mulgaonkar, S.
    Steinberg, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15